- Conditions
- Migraine
- Interventions
- Fremanezumab, Placebo
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 1,890 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 90
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 75 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 193–216
of 742
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Migraine Headache With Intractable Migraine
- Interventions
- ketamine infusion
- Drug
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Migraine
- Interventions
- AMG 333, Placebo
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Migraine Disorders
- Interventions
- Combination Product (sumatriptan succinate / naproxen sodium), Placebo
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 173 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 26
- States / cities
- Fresno, California • Newport Beach, California • Santa Monica, California + 23 more
- Conditions
- Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis
- Interventions
- OraVescent Fentanyl
- Drug
- Lead sponsor
- Cephalon
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 38
- States / cities
- Calera, Alabama • Hoover, Alabama • Phoenix, Arizona + 29 more
- Conditions
- Migraine
- Interventions
- CEFALY
- Device
- Lead sponsor
- Cefaly Technology
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Migraine Disorders
- Interventions
- NP101
- Drug
- Lead sponsor
- NuPathe Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 198 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 34
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Newport Beach, California + 31 more
- Conditions
- Obesity, Rhinitis, Rhinitis, Allergic, Respiratory Sounds, Dyspnea, Headache, Migraine Disorders, Arthritis, Arthralgia, Anxiety, Sleep Initiation and Maintenance Disorders, Sleep Deprivation
- Interventions
- Vitamin A, Vitamin B6, Vitamin C, Nicotinamide, Vitamin D3, Vitamin E, Broccoli, Spinach, Caffeine, Coffee, Axon Eyewear, Chocolate
- Dietary Supplement · Other · Device
- Lead sponsor
- Verifomics LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Migraine
- Interventions
- Placebo ZNS, ZNS
- Drug
- Lead sponsor
- Impax Laboratories, LLC
- Industry
- Eligibility
- 6 Years to 11 Years
- Enrollment
- 374 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 47
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Anaheim, California + 38 more
- Conditions
- Migraine
- Interventions
- zolmitriptan, CVT-427 (zolmitriptan inhalation powder),
- Drug
- Lead sponsor
- Acorda Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Daytona Beach, Florida • Dallas, Texas
- Conditions
- Migraine Disorders
- Interventions
- non-invasive transcranial direct current stimulation (tDCS)
- Device
- Lead sponsor
- MJHS Institute for Innovation in Palliative Care
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 2
- States / cities
- New York, New York
- Conditions
- Migraine, Episodic Migraine
- Interventions
- Galcanezumab, Rimegepant, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 580 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 77
- States / cities
- Gilbert, Arizona • Phoenix, Arizona • Tempe, Arizona + 71 more
- Conditions
- Pregnancy, Migraine, Headache, Postpartum, Depression, Anxiety
- Interventions
- external Trigeminal Nerve Stimulation
- Device
- Lead sponsor
- Cefaly Technology
- Industry
- Eligibility
- 18 Years to 44 Years · Female only
- Enrollment
- 550 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 1
- States / cities
- Darien, Connecticut
- Conditions
- Migraine Disorders
- Interventions
- DaxibotulinumtoxinA
- Drug
- Lead sponsor
- Ki Health Partners. LLC
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Stamford, Connecticut
- Conditions
- Chronic Migraine
- Interventions
- GammaCore Active Device, GammaCore Sham Device
- Device
- Lead sponsor
- ElectroCore INC
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 6
- States / cities
- San Francisco, California • Ann Arbor, Michigan • Springfield, Missouri + 3 more
- Conditions
- Primary Headache Disorders
- Interventions
- Ausanil
- Drug
- Lead sponsor
- VR1 Corporation
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Summit, New Jersey
- Conditions
- Childhood Depression, Childhood Anxiety, Pediatric Pain, Migraines, ADHD, Pediatric Stomach Pain, Musculoskeletal Pain
- Interventions
- Integrative Coping Group
- Behavioral
- Lead sponsor
- Duke University
- Other
- Eligibility
- 10 Years to 12 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Migraine
- Interventions
- Galcanezumab, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 986 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 49
- States / cities
- Phoenix, Arizona • Apple Valley, California • Los Angeles, California + 44 more
- Conditions
- Migraine Headache
- Interventions
- Stress, Fasting
- Behavioral · Other
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Chronic Migraine
- Interventions
- Nerivio
- Device
- Lead sponsor
- Theranica
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 126 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 10
- States / cities
- Newport Beach, California • Santa Monica, California • Hartford, Connecticut + 7 more
- Conditions
- Chronic Migraine Without Aura, Intractable, Migraine With Typical Aura, Migraine Disorders
- Interventions
- Dexamethasone, Lidocaine, Thiamine cohort
- Combination Product
- Lead sponsor
- Corona Doctors Medical Clinics, Inc.
- Other
- Eligibility
- 10 Years to 90 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Corona, California
- Conditions
- Migraine Disorders
- Interventions
- Emotional Awareness and Expression Therapy (EAET)
- Behavioral
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Migraine
- Interventions
- air insufflation, placebo
- Procedure
- Lead sponsor
- Carrick Institute for Graduate Studies
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona
- Conditions
- Chronic Migraine
- Interventions
- HD-tDCS Active Protocol, HD-tDCS Sham Protocol
- Device
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan